Royal Wolverhampton signs three-year deal with Medopad
The British technology companyâs solution will be introduced in a number of areas of the trust including cardiology, hypertension and diabetes.
Back to Top
The British technology companyâs solution will be introduced in a number of areas of the trust including cardiology, hypertension and diabetes.
The aim of the evaluation was to use the feedback to improve patient experience of the app and to plan support for GP practices.
The eRehabilitation Prescription is part of a 3-step discharge process, helping trauma patients leaving Southmead Hospital to better manage their aftercare
The aim of the deployment was to alert doctors to genuine prescribing dangers and forms part of a wider electronic patient record programme.
The funding boost, through the governmentâs Digital Health Technology Catalyst, aims to accelerate the development of digital health innovation.
NHS Greater Glasgow and Clyde believes the trial will result in fewer hospital visits for COPD patients â which costs about ÂŁ6,000 per admission.
Leanne Summers, digital strategy delivery lead for NHSE, also said that of the 2,650 only 270 (10%) had actually booked appointments through the app.

The government has announced ÂŁ20 million of funding to expand AI chest X-ray tools to

UK online pharmacy Pharmacy2U has launched a dedicated womenâs health hub, backed by menopause retail

Manchester University NHS Foundation Trust (MFT) is launching a data platform to support research and

Royal Cornwall Hospitals NHS Trust has delayed its Oracle EPR go-live to ensure it will
Today’s briefing features an app designed to help people manage physical ageing and a health